Pharmacological actions and potential uses of Momordica charantia: a review.
暂无分享,去创建一个
J. Grover | S. Yadav | S P Yadav | J K Grover | J. Grover
[1] H. Higashino,et al. [Hypoglycemic effects of Siamese Momordica charantia and Phyllanthus urinaria extracts in streptozotocin-induced diabetic rats (the 1st report)]. , 1992, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.
[2] N. Vijayalakshmi,et al. Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia , 2000 .
[3] T. Ng,et al. Purification and characterization of charantin, a napin-like ribosome-inactivating peptide from bitter gourd (Momordica charantia) seeds. , 2002, The journal of peptide research : official journal of the American Peptide Society.
[4] Kyosuke Yamamoto,et al. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. , 2000, Journal of ethnopharmacology.
[5] H. Yeung,et al. beta-Momorcharin, a plant glycoprotein, inhibits synthesis of macromolecules in embryos, splenocytes and tumor cells. , 1992, The International journal of biochemistry.
[6] B. Tunctan,et al. Hypoglycaemic effect of Momordica charantia extracts in normoglycaemic or cyproheptadine-induced hyperglycaemic mice. , 1994, Journal of ethnopharmacology.
[7] C. Bailey,et al. Improvement in glucose tolerance due to Momordica charantia (karela). , 1981, British medical journal.
[8] S. Ramaswamy,et al. Analgesic effect of Momordica charantia seed extract in mice and rats. , 1991, Journal of ethnopharmacology.
[9] M. Kawai,et al. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. , 2001, Journal of nutritional science and vitaminology.
[10] H. Matsuda,et al. Roles of capsaicin-sensitive sensory nerves, endogenous nitric oxide, sulfhydryls, and prostaglandins in gastroprotection by momordin Ic, an oleanolic acid oligoglycoside, on ethanol-induced gastric mucosal lesions in rats. , 1999, Life sciences.
[11] C. Chakrabarti,et al. Effects of bittergourd (Momordica charantia) seed & glibenclamide in streptozotocin induced diabetes mellitus. , 1982, Indian journal of experimental biology.
[12] R. Camerini‐Davalos. PREVENTION OF DIABETES MELLITUS. , 1965, The Medical clinics of North America.
[13] Y Srivastava,et al. Effect of Momordica charantia Linn. pomous aqueous extract on cataractogenesis in murrin alloxan diabetics. , 1988, Pharmacological research communications.
[14] M. H. Sheriff,et al. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. , 1986, Journal of ethnopharmacology.
[15] H. Yeung,et al. Effects of alpha-momorcharin on preimplantation development in the mouse. , 1984, Journal of reproduction and fertility.
[16] A. Bolognesi,et al. An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins. , 1999, Haematologica.
[17] S. Lee-Huang,et al. Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus. , 2001, Biochemical and biophysical research communications.
[18] N. Gupta,et al. Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats. , 2001, Journal of ethnopharmacology.
[19] S. Lee-Huang,et al. The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1. , 1999, Fertility and sterility.
[20] A. deFazio,et al. Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines , 1996, International journal of cancer.
[21] R. Suzuki,et al. Dietary effects of bitter gourd oil on blood and liver lipids of rats. , 2001, Archives of biochemistry and biophysics.
[22] E. Basch,et al. Bitter melon (Momordica charantia): a review of efficacy and safety. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[23] A. Kar,et al. Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. , 2003, Journal of ethnopharmacology.
[24] D. Takemoto,et al. In vivo antitumor activity of the bitter melon (Momordica charantia). , 1983, Cancer research.
[25] H. Yeung,et al. Proteins with abortifacient, ribosome inactivating, immunomodulatory, antitumor and anti-AIDS activities from Cucurbitaceae plants. , 1992, General pharmacology.
[26] E. Ríos-Olivares,et al. Plants from Puerto Rico with anti-Mycobacterium tuberculosis properties. , 1998, Puerto Rico health sciences journal.
[27] K. Bennoor,et al. Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients. , 1999, Bangladesh Medical Research Council bulletin.
[28] A. Marques,et al. Screening of the antimalarial activity of plants of the Cucurbitaceae family. , 1991, Memorias do Instituto Oswaldo Cruz.
[29] H. Yeung,et al. Effects of ginsenosides, lectins and Momordica charantia insulin-like peptide on corticosterone production by isolated rat adrenal cells. , 1987, Journal of ethnopharmacology.
[30] T. Ng,et al. Studies on the anti-mitogenic, anti-phage and hypotensive effects of several ribosome inactivating proteins. , 2001, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.
[31] H. Yeung,et al. Action of α-momorcharin, a ribosome inactivating protein, on cultured tumor cell lines , 1994 .
[32] R. Bhonde,et al. Role of bittergourd fruit juice in stz-induced diabetic state in vivo and in vitro. , 2000, Journal of ethnopharmacology.
[33] D. Bhattacharyya,et al. Nutritional Characteristics of Oil Containing Conjugated Octadecatrienoic Fatty Acid , 1998, Annals of Nutrition and Metabolism.
[34] H. Yeung,et al. The inhibitory effects of β-momorcharin on endometrial cells in the mouse , 1985 .
[35] Ravindra,et al. Antispermatogenic and androgenic activities of Momordica charantia (Karela) in albino rats. , 1998, Journal of ethnopharmacology.
[36] W. Graves,et al. Isolation of a guanylate cyclase inhibitor from the balsam pear (Momordica charantia abreviata). , 1977, Biochemical and biophysical research communications.
[37] F. Ederer,et al. Epidemiologic associations with cataract in the 1971-1972 National Health and Nutrition Examination Survey. , 1983, American journal of epidemiology.
[38] H. Yeung,et al. Effects of -momorcharin on preimplantation development in the mouse , 1984 .
[39] H. Raza,et al. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. , 2001, Diabetes research and clinical practice.
[40] S. Lee-Huang,et al. MAP 30: a new inhibitor of HIV‐1 infection and replication , 1990, FEBS letters.
[41] R. Bamezai,et al. Momordica charantia (Bitter Gourd) peel, pulp, seed and whole fruit extract inhibits mouse skin papillomagenesis. , 1998, Toxicology letters.
[42] B. A. Shibib,et al. Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. , 1993, The Biochemical journal.
[43] L. Schiller,et al. Disorders of gastrointestinal motility associated with diabetes mellitus. , 1983, Annals of internal medicine.
[44] L. Barbieri,et al. An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients. , 1989, British Journal of Cancer.
[45] L. Barbieri,et al. Toxicity ofMomordica charantia lectin and inhibitor for human normal and leukaemic lymphocytes , 1980, Virchows Archiv. B, Cell pathology including molecular pathology.
[46] C. Bailey,et al. Cerasee, a traditional treatment for diabetes. Studies in normal and streptozotocin diabetic mice. , 1985, Diabetes research.
[47] R. E. Omoregbe,et al. Antimicrobial activity of some medicinal plants extracts on Escherichia coli, Salmonella paratyphi and Shigella dysenteriae. , 1996, African journal of medicine and medical sciences.
[48] S. Jain,et al. Hypoglycemic activity of polypeptide-p from a plant source. , 1981, Journal of natural products.
[49] E. Yeşilada,et al. Screening of Turkish anti-ulcerogenic folk remedies for anti-Helicobacter pylori activity. , 1999, Journal of ethnopharmacology.
[50] S. Lee-Huang,et al. Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active. , 1999, Biochemical and biophysical research communications.
[51] H. Yeung,et al. The immunosuppressive activities of two abortifacient proteins isolated from the seeds of bitter melon (Momordica charantia). , 1987, Immunopharmacology.
[52] N. Keim,et al. Fructose, weight gain, and the insulin resistance syndrome. , 2002, The American journal of clinical nutrition.
[53] H. Yeung,et al. β-Momorcharin, a plant glycoprotein, inhibits synthesis of macromolecules in embryos, splenocytes and tumor cells , 1992 .
[54] H. Yeung,et al. Effects of momorcharins on the mouse embryo at the early organogenesis stage. , 1986, Contraception.
[55] H. Nagasawa,et al. Effects of bitter melon (Momordica charantia l.) or ginger rhizome (Zingiber offifinale rosc) on spontaneous mammary tumorigenesis in SHN mice. , 2002, The American journal of Chinese medicine.
[56] H. Yeung,et al. The termination of early pregnancy in the mouse by beta-momorcharin. , 1984, Contraception.
[57] S. Sarkar,et al. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. , 1996, Pharmacological research.
[58] S. Chandra,et al. In vitro anthelmintic action of some indigenous medicinal plants on Ascardia galli worms. , 1976, Indian journal of physiology and pharmacology.
[59] Y. Zheng,et al. Alpha-momorcharin inhibits HIV-1 replication in acutely but not chronically infected T-lymphocytes. , 1999, Zhongguo yao li xue bao = Acta pharmacologica Sinica.
[60] L. Polito,et al. Anti‐CD30 (BER‐H2) immunotoxins containing the type‐1 ribosome‐inactivating proteins momordin and PAP‐S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice , 1996, British journal of haematology.
[61] D. Takemoto,et al. Partial purification and characterization of a guanylate cyclase inhibitor with cytotoxic properties from the bitter melon (Momordica charantia). , 1980, Biochemical and biophysical research communications.
[62] S. De,et al. Prevention of carcinogen‐induced mouse skin papilloma by whole fruit aqueous extract of Momordica charantia , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[63] J. Welihinda,et al. Extra-pancreatic effects of Momordica charantia in rats. , 1986, Journal of ethnopharmacology.
[64] S. Miura,et al. Isolation and amino acid sequences of two trypsin inhibitors from the seeds of bitter gourd (Momordica charantia). , 1995, Bioscience, biotechnology, and biochemistry.
[65] S. Tyagi,et al. Effects of long term feeding of acetone extract of Momordica charantia (whole fruit powder) on alloxan diabetic albino rats. , 1989, Indian journal of physiology and pharmacology.
[66] H. Matsuda,et al. Medicinal Foodstuffs. XXI. 1) Structures of New Cucurbitane-Type Triterpene Glycosides, Goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and New Oleanane-Type Triterpene Saponins, Goyasaponins I, II, and III, from the Fresh Fruit of Japanese Momordica charantia L. , 2001 .
[67] S. Yoganarasimhan. Medicinal plants of India , 1996 .
[68] H. Matsuura,et al. α-Glucosidase Inhibitor from the Seeds of Balsam Pear (Momordica charantia) and the Fruit Bodies of Grifola frondosa , 2002, Bioscience, biotechnology, and biochemistry.
[69] C. Lau,et al. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). , 1996, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[70] C. Dunford,et al. The cytotoxic and cytostatic effects of the bitter melon (Momordica charantia) on human lymphocytes. , 1982, Toxicon : official journal of the International Society on Toxinology.
[71] M. Sauvain,et al. The search for natural bioactive compounds through a multidisciplinary approach in Bolivia. Part II. Antimalarial activity of some plants used by Mosetene indians. , 2000, Journal of ethnopharmacology.
[72] S. Lee-Huang,et al. Potentiation of anti-HIV activity of anti-inflammatory drugs, dexamethasone and indomethacin, by MAP30, the antiviral agent from bitter melon. , 1995, Biochemical and biophysical research communications.
[73] [Studies on the active constituents of Momordica charantia L]. , 1990, Yao xue xue bao = Acta pharmaceutica Sinica.
[74] J. Harding,et al. Risk factors for cataract in Oxfordshire: diabetes, peripheral neuropathy, myopia, glaucoma and diarrhoea , 1989, Acta ophthalmologica.
[75] A. Bolognesi,et al. In vitro and in vivo properties of an anti-CD5—momordin immunotoxin on normal and neoplastic T lymphocytes , 1993, Cancer Immunology, Immunotherapy.
[76] R. E. Omoregbe,et al. Antimicrobial activity of some medicinal plants extracts on Escherichia coli, Salmonella paratyphi and Shigella dysenteriae. , 1996, African journal of medicine and medical sciences.
[77] C. Lans,et al. Observations on ethnoveterinary medicines in Trinidad and Tobago. , 1998, Preventive veterinary medicine.
[78] J. Harding,et al. A case-control study of cataract in Oxfordshire: some risk factors. , 1988, The British journal of ophthalmology.
[79] C. B. Bagwell,et al. Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata). , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[80] T. Miyata,et al. Inhibition of serine proteases of the blood coagulation system by squash family protease inhibitors. , 1994, Journal of biochemistry.
[81] R. Dawar,et al. Traditional Indian anti-diabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice. , 2001, Journal of ethnopharmacology.
[82] M. Engelgau,et al. Screening for type 2 diabetes. , 2000, Diabetes care.
[83] S. Lee-Huang,et al. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[84] W. Kasinrerk,et al. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy. , 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[85] H. Yeung,et al. Toxicities of trichosanthin and alpha-momorcharin, abortifacient proteins from Chinese medicinal plants, on cultured tumor cell lines. , 1990, Toxicon : official journal of the International Society on Toxinology.
[86] S. Wood,et al. Crystal structure of momordin, a type I Ribosome Inactivating Protein from the seeds of Momordica charantia , 1994, FEBS letters.
[87] T. Ng,et al. The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV‐1 integrase , 2000, FEBS letters.
[88] Y. Ebizuka,et al. HIV inhibitor from Thai bitter gourd. , 2001, Planta medica.
[89] J. Tainer,et al. The food of sweet and bitter fancy , 2000, Nature Structural Biology.
[90] H. Yeung,et al. The termination of early pregnancy in the mouse by β-momorcharin , 1984 .
[91] T. Ng,et al. Examination of lectins, polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and glycohydrolases. , 2001, Planta medica.
[92] K. Siems,et al. In Vitro Antiplasmodial Investigation Of Medicinal Plants From El Salvador § , 2002, Zeitschrift fur Naturforschung. C, Journal of biosciences.
[93] L. Barbieri,et al. The immunomodulatory activity of the plant proteins Momordica charantia inhibitor and pokeweed antiviral protein. , 1983, International journal of immunopharmacology.
[94] Z. Wu,et al. [Study on chemical components of Momordica charantia]. , 1998, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.
[95] L. Polito,et al. Toxicity of ribosome‐inactivating proteins‐containing immunotoxins to a human bladder carcinoma cell line , 1996, International journal of cancer.
[96] S. Chapes,et al. Induction of tumor cytotoxic immune cells using a protein from the bitter melon (Momordica charantia). , 1990, Cellular immunology.
[97] B. Şener,et al. Anti-ulcerogenic effect of Momordica charantia L. fruits on various ulcer models in rats. , 2000, Journal of ethnopharmacology.
[98] L. Polito,et al. Induction of apoptosis by ribosome‐inactivating proteins and related immunotoxins , 1996, International journal of cancer.
[99] K. Hayashi,et al. Trypsin and elastase inhibitors from bitter gourd (Momordica charantia LINN.) seeds: purification, amino acid sequences, and inhibitory activities of four new inhibitors. , 1995, Journal of biochemistry.
[100] H. Nagasawa,et al. Inhibition by indomethacin of spontaneous mammary tumorigenesis in SHN mice , 2005, Breast Cancer Research and Treatment.
[101] S. Seth,et al. Medicinal plants in India. , 2004, The Indian journal of medical research.
[102] A. Tepsuwan,et al. Effects of neem flowers, Thai and Chinese bitter gourd fruits and sweet basil leaves on hepatic monooxygenases and glutathione S-transferase activities, and in vitro metabolic activation of chemical carcinogens in rats. , 1998, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[103] K. Kramer,et al. Guanylate cyclase activity in human leukemic and normal lymphocytes. Enzyme inhibition and cytotoxicity of plant extracts. , 1982, Enzyme.
[104] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[105] H. Yeung,et al. Action of alpha-momorcharin, a ribosome inactivating protein, on cultured tumor cell lines. , 1994, General Pharmacology.
[106] K. Tennekoon,et al. Effect of Momordica charantia fruit juice on streptozotocin-induced diabetes in rats. , 1990, Journal of ethnopharmacology.
[107] S. Sirimanne,et al. Oral hypoglycaemic activity of some medicinal plants of Sri Lanka. , 1984, Journal of ethnopharmacology.
[108] C. Bailey,et al. Hypoglycaemic effect of Momordica charantia extracts. , 1990, Planta medica.
[109] Akhtar Ms. Trial of Momordica charantia Linn (Karela) powder in patients with maturity-onset diabetes. , 1982 .
[110] L. Barbieri,et al. Effect of ribosome-inactivating proteins on virus-infected cells. Inhibition of virus multiplication and of protein synthesis , 2005, Archives of Virology.
[111] H. Matsuda,et al. Antidiabetic principles of natural medicines. III. Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity. , 1998, Chemical & pharmaceutical bulletin.
[112] K. Platel,et al. Influence of bitter gourd (Momordica charantia) on growth and blood constituents in albino rats. , 1993, Die Nahrung.
[113] H. Yeung,et al. Effects of momorcharins on ovarian response to gonadotropin-induced superovulation in mice. , 1988, International journal of fertility.
[114] M. Biyani,et al. Antihyperglycemic effects of three extracts from Momordica charantia. , 2003, Journal of ethnopharmacology.
[115] L. Pari,et al. Antihyperglycaemic effect of Diamed, a herbal formulation, in experimental diabetes in rats , 2001, The Journal of pharmacy and pharmacology.
[116] A. Bera,et al. Structural and interactional homology of clinically potential trypsin inhibitors: molecular modelling of cucurbitaceae family peptides using the X-ray structure of MCTI-II. , 2000, Protein engineering.
[117] S. Ghosh,et al. Dietary effects of conjugated octadecatrienoic fatty acid (9 cis, 11 trans, 13 trans) levels on blood lipids and nonenzymatic in vitro lipid peroxidation in rats , 1999, Lipids.
[118] Kyung-Tae Lee,et al. Anti-rheumatoid arthritis effect of theKochia scoparia fruits and activity comparison of momordin ic, its prosapogenin and sapogenin , 2002, Archives of pharmacal research.
[119] S. Lee-Huang,et al. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. , 1995, Gene.
[120] H. Matsuda,et al. Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. , 2001, Chemical & pharmaceutical bulletin.
[121] Jaipaul Singh,et al. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. , 1998, Diabetes research and clinical practice.
[122] J. Grover,et al. Amelioration of experimental diabetic neuropathy and gastropathy in rats following oral administration of plant (Eugenia jambolana, Mucuna pruriens and Tinospora cordifolia) extracts. , 2002, Indian journal of experimental biology.
[123] S. Lee-Huang,et al. The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus in vitro. , 1996, Biochemical and biophysical research communications.
[124] J. Grover,et al. The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism , 2002, Phytotherapy research : PTR.
[125] N. Biswas,et al. Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts , 2002, Phytotherapy research : PTR.
[126] H. Yeung,et al. Effects of α-trichosanthin and α-momorcharin on the development of peri-implantation mouse embryos , 1983 .
[127] S. Lee-Huang,et al. The Activity of Plant-Derived Antiretroviral Proteins MAP30 and GAP31 against Herpes Simplex Virus Infectionin Vitro , 1996 .
[128] Z. Xia,et al. Three-dimensional structure of beta-momorcharin at 2.55 A resolution. , 1999, Acta crystallographica. Section D, Biological crystallography.
[129] A. Cáceres,et al. Ethnobotanical survey of the medicinal flora used by the Caribs of Guatemala. , 1991, Journal of ethnopharmacology.
[130] B. Rokeya,et al. Studies on Hypoglycemic Effects of Fruit Pulp, Seed, and Whole Plant of Momordica charantia on Normal and Diabetic Model Rats , 1993, Planta medica.